Winkey’s new cosmetic ingredient β-Nicotinamide Mononucleotide (NMN) has been successfully registered in IECIC on 29 April. It is our second new ingredient in IECIC list since the Chinese New Cosmetic Regulations came out in 2021. And we also became the only enterprise that has successfully registered two cosmetic ingredients. 

As a health care product, β-Nicotinamide Mononucleotide (NMN) was once known as "the elixir". It has been extensively studied from all over the world, with research published in top scientific journals including Science, Nature, and Cell. 

Experimentally verified, NMN has been proven to be a potential skin aging solution, performing essential life processes such as anti-inflammation, oxidative stress regulation, DNA repair as well as preserving and stimulating mitochondria. 

After registered in IECIC, Winkey Technology will carry out in-depth efficacy and application research, hoping to provide high-quality cosmetic ingredients and diversified formula application solutions for downstream cosmetics enterprises.